仁和药业聘任姜锋为新任董事会秘书

Core Viewpoint - The appointment of Mr. Jiang Feng as the Secretary of the Board is a normal personnel arrangement aimed at ensuring continuity and compliance in the company's board operations [1][2] Group 1: Appointment Details - The 10th Board of Directors of Renhe Pharmaceutical Co., Ltd. held its sixth temporary meeting on February 9, 2026, where the appointment of Mr. Jiang Feng as the Secretary of the Board was approved [1] - The meeting was conducted via communication means, with all 9 directors present, and was chaired by Chairman Yang Xiao [1] - Mr. Jiang Feng's qualifications have been reviewed and approved by the Shenzhen Stock Exchange, and he has previously held various positions within the company [1] Group 2: Background of the New Secretary - Mr. Jiang Feng, born in October 1976, holds a bachelor's degree and an EMBA [1] - His career history is closely linked to the Renhe system, having served in multiple roles including Deputy Director of the Chairman's Office and Secretary of the Board [1] - He currently serves as a director of the company and does not hold any shares in the company, nor does he have any relationships with major shareholders or other board members [1] Group 3: Implications of the Appointment - The new Secretary's familiarity with the company's business and capital market operations is expected to enhance the continuity and standardization of the board's work [2] - Investors can contact the new Secretary through the company's published office phone, fax, email, and address [2]